QQQ   355.21 (+0.58%)
AAPL   182.14 (+0.87%)
MSFT   328.15 (+0.89%)
META   265.08 (+0.19%)
GOOGL   123.01 (+0.71%)
AMZN   124.24 (+-0.01%)
TSLA   246.82 (+5.09%)
NVDA   390.97 (+1.52%)
NIO   7.83 (+0.51%)
BABA   85.78 (-0.42%)
AMD   125.43 (+3.62%)
T   16.01 (-0.37%)
F   13.78 (+1.47%)
MU   65.55 (+0.35%)
CGC   0.67 (-4.16%)
GE   105.98 (-0.08%)
DIS   91.87 (-0.71%)
AMC   4.74 (+1.28%)
PFE   38.94 (-0.38%)
PYPL   63.59 (-1.01%)
NFLX   421.86 (+3.05%)
QQQ   355.21 (+0.58%)
AAPL   182.14 (+0.87%)
MSFT   328.15 (+0.89%)
META   265.08 (+0.19%)
GOOGL   123.01 (+0.71%)
AMZN   124.24 (+-0.01%)
TSLA   246.82 (+5.09%)
NVDA   390.97 (+1.52%)
NIO   7.83 (+0.51%)
BABA   85.78 (-0.42%)
AMD   125.43 (+3.62%)
T   16.01 (-0.37%)
F   13.78 (+1.47%)
MU   65.55 (+0.35%)
CGC   0.67 (-4.16%)
GE   105.98 (-0.08%)
DIS   91.87 (-0.71%)
AMC   4.74 (+1.28%)
PFE   38.94 (-0.38%)
PYPL   63.59 (-1.01%)
NFLX   421.86 (+3.05%)
QQQ   355.21 (+0.58%)
AAPL   182.14 (+0.87%)
MSFT   328.15 (+0.89%)
META   265.08 (+0.19%)
GOOGL   123.01 (+0.71%)
AMZN   124.24 (+-0.01%)
TSLA   246.82 (+5.09%)
NVDA   390.97 (+1.52%)
NIO   7.83 (+0.51%)
BABA   85.78 (-0.42%)
AMD   125.43 (+3.62%)
T   16.01 (-0.37%)
F   13.78 (+1.47%)
MU   65.55 (+0.35%)
CGC   0.67 (-4.16%)
GE   105.98 (-0.08%)
DIS   91.87 (-0.71%)
AMC   4.74 (+1.28%)
PFE   38.94 (-0.38%)
PYPL   63.59 (-1.01%)
NFLX   421.86 (+3.05%)
QQQ   355.21 (+0.58%)
AAPL   182.14 (+0.87%)
MSFT   328.15 (+0.89%)
META   265.08 (+0.19%)
GOOGL   123.01 (+0.71%)
AMZN   124.24 (+-0.01%)
TSLA   246.82 (+5.09%)
NVDA   390.97 (+1.52%)
NIO   7.83 (+0.51%)
BABA   85.78 (-0.42%)
AMD   125.43 (+3.62%)
T   16.01 (-0.37%)
F   13.78 (+1.47%)
MU   65.55 (+0.35%)
CGC   0.67 (-4.16%)
GE   105.98 (-0.08%)
DIS   91.87 (-0.71%)
AMC   4.74 (+1.28%)
PFE   38.94 (-0.38%)
PYPL   63.59 (-1.01%)
NFLX   421.86 (+3.05%)
NYSE:EHAB

Enhabit (EHAB) Stock Forecast, Price & News

$12.52
-0.45 (-3.47%)
(As of 02:33 PM ET)
Compare
Today's Range
$12.48
$13.00
50-Day Range
$10.76
$13.91
52-Week Range
$10.51
$25.25
Volume
269,991 shs
Average Volume
548,941 shs
Market Capitalization
$627.25 million
P/E Ratio
16.05
Dividend Yield
N/A
Price Target
$16.13

Enhabit MarketRank™ Forecast

Analyst Rating
Hold
2.00 Rating Score
Upside/​Downside
27.8% Upside
$16.13 Price Target
Short Interest
Bearish
7.51% of Float Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
0.28mentions of Enhabit in the last 14 days
Based on 3 Articles This Week
Insider Trading
Acquiring Shares
$286,520 Bought Last Quarter
Proj. Earnings Growth
18.84%
From $0.69 to $0.82 Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.46 out of 5 stars

Medical Sector

333rd out of 986 stocks

Home Health Care Services Industry

6th out of 8 stocks


EHAB stock logo

About Enhabit (NYSE:EHAB) Stock

Enhabit, Inc. is a leading healthcare provider that offers Medicare-certified skilled home health and hospice services in the United States. The company operates in two segments: Home Health and Hospice, providing services to adult patients needing care, including skilled nursing, physical, occupational, and speech therapy, medical social work, and home health aide services. Enhabit's hospice services include in-home services to terminally ill patients and their families to address patients' physical needs, including pain control and symptom management, and emotional and spiritual support.

Enhabit operates home health agencies in approximately 34 states, with a concentration in the southern half of the United States. As of March 31, 2022, Enhabit operates in 252 home health agencies and 99 hospice agencies across 34 states. Enhabit provides practices to treat chronic diseases and conditions, including diabetes, arthritis, hypertension,  Alzheimer's disease, spinal stenosis, low vision,  Parkinson's disease, complex wound care, osteoporosis, and chronic pain, along with disease-specific plans for patients with diabetes, post-orthopedic surgery or injury, congestive heart failure,  and respiratory diseases.

Enhabit started as HealthSouth, founded in 1984 by Beam Scrushy and Richard Scrushy. In the early 2000s, the company restructured and rebranded into Encompass Health after being caught up in an accounting scandal. In Q2 of 2022, Enhabit, the healthcare and hospice division, became an independent public company, having completed its spinoff from Encompass Health Corporation. 

Barb Jacobsmeyer was named President and CEO of Enhabit Home Health & Hospice in June 2021. Jacobsmeyer came to Enhabit from Encompass Health, where she served as the company's executive vice president of operations. 

In Q3 of 2022, Enhabit, Inc. announced the acquisition of Caring Hearts Hospice, a locally-owned hospice agency in Texas. The acquisition adds four hospice locations in Texas to Enhabit's existing presence in the state. Ehnabit continues to expand, setting aside approximately one hundred million dollars to fund future mergers and acquisitions. 

Enhabit, Inc. is committed to providing high-quality care and service to patients and their families, and its success is a testament to its dedicated team of healthcare professionals. Enhabit is well-positioned to meet the growing demand for healthcare services in the United States as a leading home health and hospice service provider. With its focus on patient care and commitment to excellence, Enhabit is poised to continue to grow and succeed in the years ahead.

Enhabit's commitment to quality care has not gone unnoticed, as they have received numerous awards and recognitions for their services. In 2021, they were named a HomeCare Elite Top Agency for the 15th year. This recognition is given to the top-performing home health agencies in the United States. They have also received a 5-star rating from the Centers for Medicare & Medicaid Services (CMS) for their home health services, indicating their high quality and patient satisfaction.

Enhabit's success can be attributed to its skilled and compassionate staff and dedication to providing comprehensive and individualized patient care. Enhabit also recognizes the importance of emotional and spiritual support for their patients and their families, particularly in hospice care. Their hospice services include pain and symptom management, spiritual counseling, palliative and dietary counseling, social worker visits, and bereavement counseling services to meet terminally ill patients and their families' individual physical, spiritual, emotional, and psychosocial needs.

Receive EHAB Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Enhabit and its competitors with MarketBeat's FREE daily newsletter.

EHAB Stock News Headlines

Enhabit (NYSE:EHAB) Trading 9.6% Higher
This Stock's Worth Researching
Uncover the buzz behind this trending stock. Read the comprehensive report here.
Brokerages Set Enhabit, Inc. (NYSE:EHAB) PT at $16.13
Graphite versus Lithium - What Investors Should Know
Over 18 million EVs will be cruising U.S roads by 2030. And every one million EVs manufactured will require 82,000 tons of the metal graphite for their batteries. That's a total of 1,476,000 tons of graphite! Graphite is actually the largest component of EV batteries - NOT lithium. Experts warn of a massive graphite shortfall, especially since North America currently has no operating graphite mines.
Enhabit, Inc (EHAB) Receives a Buy from Jefferies
Here’s Why You Should Acquire Enhabit (EHAB)
See More Headlines

EHAB Price History

EHAB Company Calendar

Last Earnings
5/09/2023
Today
6/09/2023
Next Earnings (Estimated)
8/07/2023
Fiscal Year End
12/31/2023

Industry, Sector and Symbol

Industry
Home health care services
Sub-Industry
N/A
Sector
Medical
Fax
N/A
Employees
11,000
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
$16.13
High Stock Price Forecast
$20.00
Low Stock Price Forecast
$12.00
Forecasted Upside/Downside
+25.6%
Consensus Rating
Hold
Rating Score (0-4)
2.00
Research Coverage
9 Analysts

Profitability

Net Income
$-40,400,000.00
Pretax Margin
-5.23%

Debt

Sales & Book Value

Annual Sales
$1.08 billion
Cash Flow
$4.12 per share
Book Value
$15.52 per share

Miscellaneous

Free Float
49,148,000
Market Cap
$643.28 million
Optionable
Not Optionable
Beta
N/A

Key Executives

  • Ms. Barbara Ann Jacobsmeyer B.S. (Age 57)
    M.A., P.T., Pres, CEO & Director
  • Ms. Crissy Buchanan Carlisle (Age 51)
    Chief Financial Officer
  • Mr. Dan Peoples
    Exec. VP of Sales & Marketing
  • Ms. Tanya R. Marion (Age 49)
    Chief HR Officer
  • Ms. Julie D. Jolley B.S.N. (Age 51)
    R.N., Exec. VP of Home Health & Hospice Operations
  • Ms. Jeanne Kalvaitis B.S.N.
    R.N., Exec. VP of Hospice Operations
  • Mr. Bud Langham M.B.A.
    P.T., Exec. VP of Clinical Excellence & Strategy













EHAB Stock - Frequently Asked Questions

Should I buy or sell Enhabit stock right now?

9 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Enhabit in the last year. There are currently 2 sell ratings, 5 hold ratings and 2 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "hold" EHAB shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in EHAB, but not buy additional shares or sell existing shares.
View EHAB analyst ratings
or view top-rated stocks.

What is Enhabit's stock price forecast for 2023?

9 equities research analysts have issued 1 year price objectives for Enhabit's stock. Their EHAB share price forecasts range from $12.00 to $20.00. On average, they expect the company's share price to reach $16.13 in the next year. This suggests a possible upside of 25.6% from the stock's current price.
View analysts price targets for EHAB
or view top-rated stocks among Wall Street analysts.

How have EHAB shares performed in 2023?

Enhabit's stock was trading at $13.16 at the beginning of the year. Since then, EHAB stock has decreased by 2.4% and is now trading at $12.84.
View the best growth stocks for 2023 here
.

When is Enhabit's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Monday, August 7th 2023.
View our EHAB earnings forecast
.

How were Enhabit's earnings last quarter?

Enhabit, Inc. (NYSE:EHAB) issued its earnings results on Tuesday, May, 9th. The company reported $0.09 earnings per share for the quarter, missing the consensus estimate of $0.12 by $0.03. The company earned $265.10 million during the quarter, compared to the consensus estimate of $271.88 million. Enhabit had a trailing twelve-month return on equity of 6.59% and a net margin of 3.64%.

What guidance has Enhabit issued on next quarter's earnings?

Enhabit issued an update on its FY 2023 earnings guidance on Tuesday, May, 9th. The company provided EPS guidance of $0.50-$0.89 for the period, compared to the consensus EPS estimate of $0.71. The company issued revenue guidance of $1.11 billion-$1.14 billion, compared to the consensus revenue estimate of $1.11 billion.

What is Enhabit's stock symbol?

Enhabit trades on the New York Stock Exchange (NYSE) under the ticker symbol "EHAB."

Who are Enhabit's major shareholders?

Enhabit's stock is owned by many different institutional and retail investors. Top institutional investors include BlackRock Inc. (14.08%), Systematic Financial Management LP (3.38%), Scopia Capital Management LP (3.37%), State Street Corp (3.34%), Dimensional Fund Advisors LP (2.06%) and Ameriprise Financial Inc. (1.96%). Insiders that own company stock include Barbara Ann Jacobsmeyer, Charles M Elson, Erin Hoeflinger, Gregory S Rush, Jeffrey Bolton, John E D D S Maupin Jr, L Edward Shaw Jr, Leo I Higdon Jr, Ronald Leroy Langham Jr and Tanya Renee Marion.
View institutional ownership trends
.

How do I buy shares of Enhabit?

Shares of EHAB stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Enhabit's stock price today?

One share of EHAB stock can currently be purchased for approximately $12.84.

How much money does Enhabit make?

Enhabit (NYSE:EHAB) has a market capitalization of $643.28 million and generates $1.08 billion in revenue each year. The company earns $-40,400,000.00 in net income (profit) each year or $0.78 on an earnings per share basis.

How many employees does Enhabit have?

The company employs 11,000 workers across the globe.

How can I contact Enhabit?

The official website for the company is www.ehab.com. The company can be reached via phone at 214-239-6500 or via email at investorrelations@ehab.com.

This page (NYSE:EHAB) was last updated on 6/9/2023 by MarketBeat.com Staff

My Account -